Patents by Inventor Kurt Rauchle

Kurt Rauchle has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Diethylene glycol monoester derivatives, compositions and therapeutic use
    Patent number: 4960793
    Abstract: Novel diethylene glycol monoester of antirheumatically effective acids, e.g., lonazolac and diclofenac and others are disclosed which have inflammation inhibitory properties superior to the corresponding acid base forms. They may be produced through direct esterification without elimination of water and are suitable in the fight against diseases of the rheumatic complex.
    Type: Grant
    Filed: March 31, 1989
    Date of Patent: October 2, 1990
    Assignee: Merckle GmbH
    Inventors: Gunter Metz, Kurt Rauchle, Manfred Erdmann
  • Liquid diclofenac preparations
    Patent number: 4711906
    Abstract: Disclosed are aqueous, stable, relatively concentrated solutions of diclofenac, which contain a mixture of propylene glycol and polyethylene glycol in defined quantitative proportions. The solutions preferably contain a local anesthetic such as lidocaine and a reducing agent as stabilizer.
    Type: Grant
    Filed: December 20, 1985
    Date of Patent: December 8, 1987
    Assignee: Merckle GmbH
    Inventors: Otto von Stetten, Pyare L. Seth, Franz Schmid, Kurt Rauchle
  • Pharmaceutical for the treatment of sleep disorders
    Patent number: 4505914
    Abstract: At least one barbiturate or one of its pharmaceutically acceptable salts is combined with cinnarizine or flunarizine or one of their pharmaceutically acceptable salts to provide a hypnotic requiring lower dosages of barbiturates to produce the same effect as the barbiturate alone.
    Type: Grant
    Filed: July 29, 1983
    Date of Patent: March 19, 1985
    Assignee: Merckle GmbH
    Inventors: Gunter Metz, Kurt Rauchle